Transparency is extremely important to us, so we are letting you know that we may receive a commission on some of links you click on from this page. See our disclaimer.

We're still enjoying summer and don't want to think about flu season yet, but a newly published study is worth noting.

As the New York Times writes: “Flu Vaccine Has Added Benefits for People With Diabetes.” The piece begins: “People with Type 2 diabetes may get an added benefit from the flu vaccine: a reduced risk of cardiovascular disease.”

The report is based on a study published in the Canadian Medical Association Journal titled, “Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes.”

As the report states: “The health burden caused by seasonal influenza is substantial. We sought to examine the effectiveness of influenza vaccination against admission to hospital for acute cardiovascular and respiratory conditions and all-cause death in people with type 2 diabetes.”

The report concludes: “In this cohort of patients with type 2 diabetes, influenza vaccination was asso- ciated with reductions in rates of admission to hospital for specific cardiovascular events. Efforts should be focused on improvements in vaccine uptake in this important target group as part of comprehensive secondary prevention.”

In addition — particularly as workplaces prepare for the flu season — the report states: “These findings underline the importance of in influenza vaccination as part of comprehensive secondary prevention in this high-risk population.”